Thirty-Day Outcome of a Multicenter Registry Study of Stenting for Symptomatic Intracranial Artery Stenosis in China
Author(s) -
Zhongrong Miao,
Yong Zhang,
Jie Shuai,
Changchun Jiang,
Qiyi Zhu,
Kangning Chen,
Li Liu,
Baomin Li,
Xiangqun Shi,
Lianbo Gao,
Yajie Liu,
Feng Wang,
Yongli Li,
TieYan Liu,
Hongbo Zheng,
Yilong Wang,
Yongjun Wang
Publication year - 2015
Publication title -
stroke
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.397
H-Index - 319
eISSN - 1524-4628
pISSN - 0039-2499
DOI - 10.1161/strokeaha.115.010549
Subject(s) - medicine , stenosis , stent , stroke (engine) , balloon , surgery , angioplasty , revascularization , radiology , middle cerebral artery , ischemia , myocardial infarction , mechanical engineering , engineering
Although recent trials have suggested that stenting is worse than medical therapy for patients with severe symptomatic intracranial atherosclerotic stenosis, it is not clear whether this conclusion applies to a subset of patients with hypoperfusion symptoms. To justify for a new trial in China, we performed a multicenter prospective registry study to evaluate the safety and efficacy of endovascular stenting within 30 days for patients with severe symptomatic intracranial atherosclerotic stenosis.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom